Microarray ELISA for autoantibody screening in connective tissue diseases

Journal of Clinical and Diagnostic Research

Volumn 6, Issue 2, 2012, Pages 200-206

  Kumble, Sarita ^a   Choi, Lok ^a   Lopez Muedano, Carlos ^a   Kumble, Krishnanand D ^a  

^a Pictor Limited   (New Zealand)

Author keywords

Autoantibodies; Autoantigens; Connective tissue disease; Immunoassay; Microarrays; Systemic rheumatic disease

Indexed keywords

AUTOANTIBODY; CENTROMERE PROTEIN B; JO 1 ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY;

ANTIBODY SCREENING; ANTIGEN BINDING; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE TEST; MICROARRAY ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

EID: 84860184479     PISSN: 2249782X     EISSN: 0973709X     Source Type: Journal    
DOI: JCDR/3954:1943     Document Type: Article

References (22)

1. McBride JD, Gabriel FG, Fordham J, Kolind T, Barcenas-Morales G, Isenberg DA, et al. Screening autoantibody profles in systemic rheumatic disease with a diagnostic protein microarray that uses a fltration-assisted nanodot array luminometric immunoassay (NALIA). Clin Chem. 2008;54:883-890.
2. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med, 2001;345:340-50.
3. Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nature Med. 2001;7:899-905.
4. Kavanaugh A, Tomar R, Reveille J, Solomon DH, Homburger HA. Guidelines for the clinical use of the antinuclear antibody test and the tests for the specifc autoantibodies to the nuclear antigens. Arch Pathol Lab Med. 2000;124:71-81.
5. Moder KG. Use and interpretation of rheumatologic tests: a guide for clinicians. Mayo Clin Proc 1996;71:391-396.
6. Rouquette A-M, Desgruelles C, Laroche P. Evaluation of the multiplexed immunoassay, FIDIS, for the simultaneous quantitative determination of antinuclear antibodies and for comparison with the conventional methods. Am J Clin Path. 2003;120:676-681.
7. Buliard A, Fortenfant F, Ghillani-Dalbin P, Musset L, Oksman F, Olsson NO. Analysis of nine autoantibodies which were associated with systemic autoimmune diseases by using the Luminex technology. Results of a multicenter study. Ann Biol Clin (Paris). 2005;63:51-58.
8. Prestigiacomo T, Humbel RL, Larida B, Binder SR. Multiplexed analysis of thirteen antibodies by using the BioPlex 2200 fully automated immunoassay analyzer. Autoantigens, autoantibodies. In: Conrad K. Sack U editors. Autoantigens, autoantibodies, autoimmunity. Lengerich; 2004;463-468.
9. Yager P, Domingo GJ, Gerdes J. Point-of-care diagnostics for global health. Ann Rev Biomed Eng. 2008;10:107-144.
10. Shapira Y, Agmon-Levin N, Shoenfeld Y. Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rhematol. 2010;6:468-476.
11. Mabey D, Peeling RW, Ustianowski A, Perkins MD. Diagnostics for the developing world. Nat Rev Microbiol. 2004;2:231-240.
12. Balboni I, Chan SM, Kattah M, Tenenbaum JD, Butte A, Utz PJ. Multiplexed protein array platforms for the analysis of autoimmune diseases. Ann Rev Immunol. 2006;24:391-418.
13. Jaskowski TD, Schroder C, Martins TB, Mouritsen CL, Litwin CM, Hill HR. Screening for antinuclear antibodies by doing enzyme immunoassay. Am J Clin Pathol. 1996;105:468-473.
14. Kang I, Siperstein R, Quan T, Breitenstein ML. Utility of age, gender and the ANA titer and pattern as the predictors of the anti-ENA and the ds-DNA antibodies. Clin Rheumatol. 2004;23:509-515.
15. Froelich CJ, Wallman J, Skosey JL, Teodorescu M. Clinical evaluation of an integrated ELISA system for the detection of 6 autoantibodies. J Rheumatol. 1090;17:192-200.
16. Dahle C, Skogh T, Aberg AK, Jalal A, Olcen P. Methods of choice for diagnostic antinuclear antibody (ANA) screening. The beneft of adding antigen-specifc assays to immunofuorescence microscopy. J. Autoimmun. 2004;22:241-248.
17. Bossuyt X, Luyckx A. Antibodies to the extractable nuclear antigens in antinuclear antibody-negative samples. Clin Chem. 2005;51:12-13.
18. Hanly JG, Thompson K, McCurdy G, Fougere L, Theriault C, Wilston K. Measurement of autoantibodies by using the multiplex methodology in patients with systemic lupus erythematosus. J. Immunol Methods. 2010;352:147-152.
19. Maguire GA, Ginawi A, Lee J, Lim AY, Wood G, Houghton S, et al. Clinical utility of ANA which was measured by ELISA as compared to ANA which was measured by immunofuorescence. Rheumatol. 2009;48:1013-1014.
20. Binder SR. Autoantibody detection by using multiplex technologies. Lupus. 2006;15:412-421.
21. Nifi A-P, Notas G, Mamoulaki M, Niniraki M, Ampartzaki V, Theodor-opoulos PA, et al. Comparison of a multiplex, bead-based fuorescent assay and immunofuorescence methods for the detection of the ANA and ANCA autoantibodies in human serum. J. Immunol Methods. 2006;311:189-197
22. Hanly JG, Su L, Farewell V, Fritzler MJ. Comparison between the multiplex assays for autoantibody detection in systemic lupus erythematosus. J. Immunol Methods. 2010;358:75-80.